Navigation Links
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
Date:10/17/2007

Latest Randomized Clinical Trial Results of First Pro-Healing Stent Also

Featured at Annual Symposium

HONG KONG, Oct. 18 /PRNewswire/ -- OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is the subject of several sessions about innovation in interventional cardiology strategies and device design at this year's Transcatheter Cardiovascular Therapeutics symposium, TCT 2007, which is set for Oct. 20-25 at the Washington Convention Center in Washington, D.C.

The line-up of sessions that feature the first pro-healing stent, which is an alternative to drug-eluting stents, includes:

- Interventional Strategies and Adjunct Pharmacology in ACS and AMI;

Should Specialized DES for AMI be Developed? Early Experience with EPC

Capture Technology; Jan Henk Dambrink, M.D., Ph.D., Department of

Cardiology, ISALA Klinieken, Hospital De Weezenlanden, Zwolle, The

Netherlands; 2:10 p.m. EDT on Oct. 21; Room 151B

- Innovative Devices and Futuristic Concepts: Novel Bare Metal and Drug-

Eluting Stents; The Genous Stent Coating with CD34 Antibodies to

Actively Capture Circulating EPCs: Design Parameters and Effects on

Healing and Thrombogenicity; Michael Kutryk, M.D., clinician scientist

and interventional cardiologist at St. Michael's Hospital, assistant

professor at the University of Toronto; Canada; 3:08 p.m. EDT on Oct.

21; Room 152A

In addition, the latest results from clinical trials of the Genous stent will be discussed by Robbert de Winter, M.D., Ph.D., principal investigator and director of the catheterization laboratory at the Academic Medical Center in Amsterdam. Specifically, de Winter will present:

- Updates from the HEALING studies, AMC "Real World" registry and TRIAS

trial; 4:36 p.m. EDT on Oct. 21; Ballroom C, 3rd floor

- A late-breaking report of six-month clinical outcomes from the TRIAS HR

pilot study: a
'/>"/>

SOURCE OrbusNeich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
5. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
6. Pharmathenes Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimers Research
7. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimers Research
8. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  Novation, a VHA and UHC ... breakthrough interactive features that automate key health care ... Children,s Hospital Association.  The new ... umbrella – Value Analysis, Item Master and Formulary ... address the most critical challenges brought on by ...
(Date:7/29/2014)... July 29, 2014  The BioFusionary Corporation, Inc. ... a proprietary electromagnetic induction platform with aesthetic and ... agreement under which TBC will merge with ... in an all-stock transaction. Upon completion ... on the Australian Stock Exchange under the code ...
(Date:7/29/2014)... -- Encision Inc. (OTCQB:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of $2.476 ... or $(0.02) per share. These results compare to net ... $311 thousand, or $(0.04) per share, in the year-ago ...
Breaking Medicine Technology:Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... , , , SAN FRANCISCO, Dec. 14 ... its promised announcement about health hazards of bisphenol A (BPA), ... harm and other illnesses, in time for Christmas. , ... Natural Resources Defense Council : "Just as you rely on ...
... ,Dec. 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... received a complete response letter from the U.S. Food ... Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in February ... approve the Company,s NDA in its present form and ...
Cached Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3
(Date:7/29/2014)... should significantly reform the federal system for financing ... the public,s $15 billion annual investment is producing ... new report by the Institute of Medicine. ... requires little accountability, allocates funds independent of workforce ... to train physicians in the health care settings ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
(Date:7/29/2014)... health institutions, including Penn State College of Medicine, ... and expand a health data research network., The ... through the Patient Protection and Affordable Care Act, ... Pittsburgh, Temple University and Johns Hopkins University -- ... four universities have come together to create a ...
(Date:7/29/2014)... According to a new report series ... authority in medical device market research, the Global ... $8 billion by 2018. This growth will be ... heart valve market, which is comprised of both the ... valve repair (TMVR) segments. , There are many risks ...
(Date:7/29/2014)... the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the ... improve access to essential pain medications for people living ... Treat the Pain initiative, this new partnership will help ... services throughout the country. , Swaziland has the ... 26 percent of adults ages 15-49 infected. Many of ...
Breaking Medicine News(10 mins):Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:New network unites university health care research 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3Health News:New partnership to improve access to essential pain medications for people living with HIV 2
... quality of life, study finds , , SATURDAY, March ... tea and acupuncture, may safely and effectively help ... Use of Erka Shizheng Herbal Tea, a bath ... the severity of the itchy, red skin condition and ...
... MINNEAPOLIS, March 13 HealthFitness Corporation (NYSE ... health and productivity management solutions, announced today that Gregg ... Winnekins, chief financial officer, will present at the B. ... Conference on Thursday, March 19, 2009 at 11:00 a.m. ...
... Cardiovascular Institute achieves milestone outcomes for heart transplantCHICAGO, ... United Network of Organ Sharing (UNOS) shows that ... achieved the largest volumes and top-rated outcomes in ... among the top 20 heart transplant programs nationally. ...
... ovary removal is another reproductive factor linked to cardiovascular ... -- The things that affect a woman,s reproductive health ... research shows. , Giving birth prematurely or delivering a ... of cardiovascular disease in the mother, according to two ...
... 13 Stryker Corporation (NYSE: SYK ) announced today that ... that will be held:, April ... Radisson Plaza Hotel, ... both the audio and the video presentation from the meeting, is available ...
... In the ongoing effort to ensure physician and ... (ABMS) is convening consumer, legislative and purchaser stakeholders for ... ABMS is the not-for-profit organization that oversees U.S. ... at the forum are Janet M. Corrigan, PhD, MBA, ...
Cached Medicine News:Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 2Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 3Health News:Preemie Delivery Tied to Later Heart Woes for Women 2Health News:Preemie Delivery Tied to Later Heart Woes for Women 3Health News:Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting 2Health News:ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards 2Health News:ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards 3
... ACMI™ USA Elite System Rotating Continuous Flow ... the urologist to rotate the working element ... of the sheaths. The result no ... tangled tubing due to rotating flow ports, ...
... PC-based ECG device that can be ... an innovative software. The system enables ... using a standard 12-lead setup that ... software includes two applications: Rest ECG ...
Used for traversing and exploring urethral strictures. The malleable tip can be shaped to desired configuration. The proximal end is threaded to attach to standard followers. Supplied sterile in peel...
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: